These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17075545)

  • 1. [Anti-inflammatory effects of macrolides: applications in lung disease].
    Langelot M; Cellerin L; Germaud P
    Rev Pneumol Clin; 2006 Sep; 62(4):215-22. PubMed ID: 17075545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Usefulness of macrolides as anti-inflammatories in respiratory diseases].
    Sevilla-Sánchez D; Soy-Muner D; Soler-Porcar N
    Arch Bronconeumol; 2010 May; 46(5):244-54. PubMed ID: 19962815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of the immunomodulatory effects of macrolides.
    Tamaoki J; Kadota J; Takizawa H
    Am J Med; 2004 Nov; 117 Suppl 9A():5S-11S. PubMed ID: 15586558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory effects of macrolides: implications for practicing clinicians.
    Siddiqui J
    Am J Med; 2004 Nov; 117 Suppl 9A():26S-29S. PubMed ID: 15586561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory effects of macrolides in childhood lung diseases.
    Luisi F; Gandolfi TD; Daudt AD; Sanvitto JP; Pitrez PM; Pinto LA
    J Bras Pneumol; 2012; 38(6):786-96. PubMed ID: 23288126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
    King P
    Drugs; 2007; 67(7):965-74. PubMed ID: 17488142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators.
    Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2008 Jan; 31(1):12-20. PubMed ID: 17935949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases.
    López-Boado YS; Rubin BK
    Curr Opin Pharmacol; 2008 Jun; 8(3):286-91. PubMed ID: 18339582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW
    J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory effects of macrolides in lung disease.
    Jaffé A; Bush A
    Pediatr Pulmonol; 2001 Jun; 31(6):464-73. PubMed ID: 11389580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying lessons learned in the treatment of diffuse panbronchiolitis to other chronic inflammatory diseases.
    Kudoh S
    Am J Med; 2004 Nov; 117 Suppl 9A():12S-19S. PubMed ID: 15586559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Macrolides. Antiinflammatory and immunomodulator effects. Indication in respiratory diseases].
    Sacre Hazouri JA
    Rev Alerg Mex; 2006; 53(3):108-22. PubMed ID: 16970113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections.
    Kobayashi H
    Treat Respir Med; 2005; 4(4):241-53. PubMed ID: 16086598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Why use long-term macrolide therapy in pediatric pulmonology?].
    Corvol H; Taytard J; Thouvenin G; Périsson C; Nathan N; Clement A
    Arch Pediatr; 2014 Mar; 21(3):314-21. PubMed ID: 24503457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory effects of macrolides: applications in chronic rhinosinusitis.
    Harvey RJ; Wallwork BD; Lund VJ
    Immunol Allergy Clin North Am; 2009 Nov; 29(4):689-703. PubMed ID: 19879444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [LONG TERM TREATMENT WITH MACROLIDES IN CHRONIC LUNG DISEASES].
    Shteinberg M; Schneer S; Lavon O; Adir Y
    Harefuah; 2016 Sep; 155(9):567-571. PubMed ID: 28530085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide antibiotics, bacterial populations and inflammatory airway disease.
    Swords WE; Rubin BK
    Neth J Med; 2003 Jul; 61(7):242-8. PubMed ID: 14567521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases.
    Eraković Haber V; Bosnar M; Kragol G
    Future Med Chem; 2014 Apr; 6(6):657-74. PubMed ID: 24895894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.
    Cameron EJ; McSharry C; Chaudhuri R; Farrow S; Thomson NC
    Clin Exp Allergy; 2012 Sep; 42(9):1302-12. PubMed ID: 22925316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of the immunomodulatory effects of macrolides on sinusitis.
    Majima Y
    Am J Med; 2004 Nov; 117 Suppl 9A():20S-25S. PubMed ID: 15586560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.